BCA
CEMI

Benchmark Capital Advisors’s Chembio diagnostics, Inc. CEMI Stock Holding History

Benchmark Capital Advisors’s Portfolio CEMI Stock Details CEMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		$515K Sell
90,929
-9,606
-10% -$70.8K 0.51% 56
2018
Q3 		$1.06M Buy
100,535
+4,300
+4% +$46.2K 0.79% 39
2018
Q2 		$1.07M Buy
96,235
+21,143
+28% +$190K 0.81% 43
2018
Q1 		$601K Buy
75,092
+8,675
+13% +$69.3K 0.48% 58
2017
Q4 		$545K Buy
66,417
+33,517
+102% +$227K 0.43% 65
2017
Q3 		$204K Buy
32,900
+20,900
+174% +$129K 0.16% 121
2017
Q2 		$73K Buy
+12,000
New +$74.9K 0.06% 133

Other funds holding CEMI

CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Benchmark Capital Advisors's CEMI Position: Q4 2018 in Review

Benchmark Capital Advisors reduced its Chembio diagnostics, Inc. (CEMI) stake by 9.6% in Q4 2018, selling an estimated $70.8K and leaving 90,929 shares worth $515K. The position accounts for 0.51% of the portfolio, ranked #56.

Benchmark Capital Advisors first reported a position in CEMI in Q2 2017 and has held it in 7 quarters since. The position peaked at $1.07M in Q2 2018. 42 funds tracked by Wall St. Rank hold CEMI as of Q4 2018.

  • Benchmark Capital Advisors held 90,929 shares of Chembio diagnostics, Inc. worth $515K as of Q4 2018.
  • Benchmark Capital Advisors sold 9,606 Chembio diagnostics, Inc. shares in Q4 2018, an estimated $70.8K.
  • Chembio diagnostics, Inc. made up 0.51% of Benchmark Capital Advisors's portfolio in Q4 2018, its #56 holding.
  • Benchmark Capital Advisors first reported a position in Chembio diagnostics, Inc. in Q2 2017 and has held it in 7 quarters since.
  • Benchmark Capital Advisors's Chembio diagnostics, Inc. position peaked at $1.07M in Q2 2018.
  • 42 funds tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q4 2018.

Based on Benchmark Capital Advisors's 13F filing for Q4 2018, filed 11 Feb 2019.